ArticleBreast cancer research : BCR2011

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.

Yuqing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.